# Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy

> **NCT01871207** · — · COMPLETED · sponsor: **Università degli Studi di Brescia** · enrollment: 53 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01871207
- **Lead sponsor:** Università degli Studi di Brescia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2013-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01871207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01871207, "Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01871207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*